Literature DB >> 1444236

The response of breast cancer cells to steroid and peptide growth factors.

J Godden1, R Leake, D J Kerr.   

Abstract

Four breast cancer cell lines covering a wide range of receptor characteristics were examined for their growth responses to oestradiol, insulin, EGF and the anti-oestrogen, tamoxifen. Stimulated cellular growth using both the MTT assay and 3H-thymidine incorporation into DNA, was measured against controls grown in a steroid reduced environment. The ER positive MCF-7 cell line showed clear growth responses to E2, insulin and EGF. This was also demonstrated, although to a lesser extent in the ZR-75-1 line which expresses lower levels of ER. In combination, these factors gave an additive growth response but the addition of EGF to maximal concentrations of insulin and oestradiol produced no further increase in growth. In contrast to these results, the two ER negative cell lines examined, MCF-7 Adr and MDA-MB-231 showed no growth response to exogenously applied steroids and in the case of MCF-7 Adr high concentrations of EGF were able to inhibit the growth of this cell line. They also showed high rates of growth in a steroid depleted environment which tends to suggest these cells are growing autonomously through autocrine growth factor induction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444236

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum.

Authors:  Amin Esfahani; Cyril W C Kendall; Balachandran Bashyam; Michael C Archer; David J A Jenkins
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-10-07       Impact factor: 2.416

2.  Expression of Q227L-galphas in MCF-7 human breast cancer cells inhibits tumorigenesis.

Authors:  J Chen; J A Bander; T A Santore; Y Chen; P T Ram; M J Smit; R Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.

Authors:  Celina G Kleer; Yanhong Zhang; Quintin Pan; Sofia D Merajver
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

4.  The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells.

Authors:  R P Hoey; C Sanderson; J Iddon; G Brady; N J Bundred; N G Anderson
Journal:  Br J Cancer       Date:  2003-02-24       Impact factor: 7.640

5.  2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway.

Authors:  Arijit Bhowmik; Nilanjana Das; Uttam Pal; Madhumita Mandal; Seemana Bhattacharya; Moumita Sarkar; Parasuraman Jaisankar; Nakul C Maiti; Mrinal K Ghosh
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

6.  Reciprocal interactions between breast tumor and its adipose microenvironment based on a 3D adipose equivalent model.

Authors:  Laetitia Delort; Charlotte Lequeux; Virginie Dubois; Alice Dubouloz; Hermine Billard; Ali Mojallal; Odile Damour; Marie-Paule Vasson; Florence Caldefie-Chézet
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

7.  Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells.

Authors:  Heather L Watt; Ujendra Kumar
Journal:  Cancer Cell Int       Date:  2006-03-06       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.